{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:35:54Z","timestamp":1785796554020,"version":"3.56.0"},"reference-count":117,"publisher":"Springer Science and Business Media LLC","issue":"20","license":[{"start":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T00:00:00Z","timestamp":1561593600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T00:00:00Z","timestamp":1561593600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"crossref","award":["MOST 107-2314-B-038 -099 -MY3"],"award-info":[{"award-number":["MOST 107-2314-B-038 -099 -MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Taipei Medical University, Wan Fang Hospital","award":["107-wf-swf-02"],"award-info":[{"award-number":["107-wf-swf-02"]}]},{"name":"Taipei Medical University, Wan Fang Hospital","award":["108-wf-swf-02"],"award-info":[{"award-number":["108-wf-swf-02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00018-019-03204-3","type":"journal-article","created":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T08:24:23Z","timestamp":1561623863000},"page":"4103-4115","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Therapeutic potential of vitamin D in AGE\/RAGE-related cardiovascular diseases"],"prefix":"10.1007","volume":"76","author":[{"given":"Ting-Wei","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hsun","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Jen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tze-Fan","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7058-2868","authenticated-orcid":false,"given":"Ting-I","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,27]]},"reference":[{"key":"3204_CR1","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","volume":"414","author":"M Brownlee","year":"2001","unstructured":"Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813\u2013820","journal-title":"Nature"},{"key":"3204_CR2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.atherosclerosis.2014.04.013","volume":"235","author":"JR Kizer","year":"2014","unstructured":"Kizer JR, Benkeser D, Arnold AM, Ix JH, Mukamal KJ, Djousse L, Tracy RP, Siscovick DS, Psaty BM, Zieman SJ (2014) Advanced glycation\/glycoxidation endproduct carboxymethyl-lysine and incidence of coronary heart disease and stroke in older adults. Atherosclerosis 235:116\u2013121","journal-title":"Atherosclerosis"},{"key":"3204_CR3","doi-asserted-by":"crossref","first-page":"570","DOI":"10.2337\/dc17-1740","volume":"41","author":"J Koska","year":"2018","unstructured":"Koska J, Saremi A, Howell S, Bahn G, De Courten B (2018) Advanced glycation end products, oxidation products, and incident cardiovascular events in patients with type 2 diabetes. Diabetes Care 41:570\u2013576","journal-title":"Diabetes Care"},{"key":"3204_CR4","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3390\/nu2121247","volume":"2","author":"C Luevano-Contreras","year":"2010","unstructured":"Luevano-Contreras C, Chapman-Novakofski K (2010) Dietary advanced glycation end products and aging. Nutrients 2:1247\u20131265","journal-title":"Nutrients"},{"key":"3204_CR5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1515\/cclm-2012-0878","volume":"52","author":"JL Scheijen","year":"2014","unstructured":"Scheijen JL, Schalkwijk CG (2014) Quantification of glyoxal, methylglyoxal and 3-deoxyglucosone in blood and plasma by ultra performance liquid chromatography tandem mass spectrometry: evaluation of blood specimen. Clin Chem Lab Med 52:85\u201391","journal-title":"Clin Chem Lab Med"},{"key":"3204_CR6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1042\/CS20100501","volume":"121","author":"DP Barlovic","year":"2011","unstructured":"Barlovic DP, Soro-Paavonen A, Jandeleit-Dahm KA (2011) RAGE biology, atherosclerosis and diabetes. Clin Sci (Lond) 121:43\u201355","journal-title":"Clin Sci (Lond)"},{"key":"3204_CR7","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.2337\/diacare.15.12.1835","volume":"15","author":"M Brownlee","year":"1992","unstructured":"Brownlee M (1992) Glycation products and the pathogenesis of diabetic complications. Diabetes Care 15:1835\u20131843","journal-title":"Diabetes Care"},{"key":"3204_CR8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.exger.2010.11.007","volume":"46","author":"S Yamagishi","year":"2011","unstructured":"Yamagishi S (2011) Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes. Exp Gerontol 46:217\u2013224","journal-title":"Exp Gerontol"},{"key":"3204_CR9","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.redox.2013.12.016","volume":"2","author":"C Ott","year":"2014","unstructured":"Ott C, Jacobs K, Haucke E, Navarrete Santos A, Grune T, Simm A (2014) Role of advanced glycation end products in cellular signaling. Redox Biol 2:411\u2013429","journal-title":"Redox Biol"},{"key":"3204_CR10","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s00109-005-0688-7","volume":"83","author":"A Bierhaus","year":"2005","unstructured":"Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T, Arnold B, Stern DM, Nawroth PP (2005) Understanding RAGE, the receptor for advanced glycation end products. J Mol Med (Berl) 83:876\u2013886","journal-title":"J Mol Med (Berl)"},{"key":"3204_CR11","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.2174\/092986710791331086","volume":"17","author":"P Alexiou","year":"2010","unstructured":"Alexiou P, Chatzopoulou M, Pegklidou K, Demopoulos VJ (2010) RAGE: a multi-ligand receptor unveiling novel insights in health and disease. Curr Med Chem 17:2232\u20132252","journal-title":"Curr Med Chem"},{"key":"3204_CR12","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1210\/er.2008-0004","volume":"29","author":"R Bouillon","year":"2008","unstructured":"Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, Lieben L, Mathieu C, Demay M (2008) Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 29:726\u2013776","journal-title":"Endocr Rev"},{"key":"3204_CR13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.nutres.2015.02.005","volume":"35","author":"TW Lee","year":"2015","unstructured":"Lee TW, Lee TI, Chang CJ, Lien GS, Kao YH, Chao TF, Chen YJ (2015) Potential of vitamin D in treating diabetic cardiomyopathy. Nutr Res 35:269\u2013279","journal-title":"Nutr Res"},{"key":"3204_CR14","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nrcardio.2016.73","volume":"13","author":"S Pilz","year":"2016","unstructured":"Pilz S, Verheyen N, Grubler MR, Tomaschitz A, Marz W (2016) Vitamin D and cardiovascular disease prevention. Nat Rev Cardiol 13:404\u2013417","journal-title":"Nat Rev Cardiol"},{"key":"3204_CR15","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijcard.2014.02.041","volume":"173","author":"TW Lee","year":"2014","unstructured":"Lee TW, Kao YH, Lee TI, Chang CJ, Lien GS, Chen YJ (2014) Calcitriol modulates receptor for advanced glycation end products (RAGE) in diabetic hearts. Int J Cardiol 173:236\u2013241","journal-title":"Int J Cardiol"},{"key":"3204_CR16","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/eci.12789","volume":"47","author":"TW Lee","year":"2017","unstructured":"Lee TW, Kao YH, Lee TI, Chen YJ (2017) ADAM10 modulates calcitriol-regulated RAGE in cardiomyocytes. Eur J Clin Investig 47:675\u2013683","journal-title":"Eur J Clin Investig"},{"key":"3204_CR17","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1096\/fj.02-0490fje","volume":"17","author":"B Xu","year":"2003","unstructured":"Xu B, Chibber R, Ruggiero D, Kohner E, Ritter J, Ferro A (2003) Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products. FASEB J 17:1289\u20131291","journal-title":"FASEB J"},{"key":"3204_CR18","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1527-5299.2004.03223.x","volume":"10","author":"S Zieman","year":"2004","unstructured":"Zieman S, Kass D (2004) Advanced glycation end product cross-linking: pathophysiologic role and therapeutic target in cardiovascular disease. Congest Heart Fail 10:144\u2013149 (quiz 150\u2013141)","journal-title":"Congest Heart Fail"},{"key":"3204_CR19","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.2337\/diabetes.48.7.1443","volume":"48","author":"GF Avendano","year":"1999","unstructured":"Avendano GF, Agarwal RK, Bashey RI, Lyons MM, Soni BJ, Jyothirmayi GN, Regan TJ (1999) Effects of glucose intolerance on myocardial function and collagen-linked glycation. Diabetes 48:1443\u20131447","journal-title":"Diabetes"},{"key":"3204_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/rp.56.1.1","volume":"56","author":"P Ulrich","year":"2001","unstructured":"Ulrich P, Cerami A (2001) Protein glycation, diabetes, and aging. Recent Prog Horm Res 56:1\u201321","journal-title":"Recent Prog Horm Res"},{"key":"3204_CR21","doi-asserted-by":"crossref","first-page":"938","DOI":"10.2337\/diab.34.9.938","volume":"34","author":"M Brownlee","year":"1985","unstructured":"Brownlee M, Vlassara H, Cerami A (1985) Nonenzymatic glycosylation products on collagen covalently trap low-density lipoprotein. Diabetes 34:938\u2013941","journal-title":"Diabetes"},{"key":"3204_CR22","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.coph.2013.06.009","volume":"13","author":"MS Ward","year":"2013","unstructured":"Ward MS, Fortheringham AK, Cooper ME, Forbes JM (2013) Targeting advanced glycation endproducts and mitochondrial dysfunction in cardiovascular disease. Curr Opin Pharmacol 13:654\u2013661","journal-title":"Curr Opin Pharmacol"},{"key":"3204_CR23","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1111\/j.1582-4934.2008.00547.x","volume":"13","author":"H Ma","year":"2009","unstructured":"Ma H, Li SY, Xu P, Babcock SA, Dolence EK, Brownlee M, Li J, Ren J (2009) Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up-regulation contribute to the onset of diabetic cardiomyopathy. J Cell Mol Med 13:1751\u20131764","journal-title":"J Cell Mol Med"},{"key":"3204_CR24","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1172\/JCI57144","volume":"121","author":"BT Bikman","year":"2011","unstructured":"Bikman BT, Summers SA (2011) Ceramides as modulators of cellular and whole-body metabolism. J Clin Investig 121:4222\u20134230","journal-title":"J Clin Investig"},{"key":"3204_CR25","doi-asserted-by":"crossref","first-page":"H63","DOI":"10.1152\/ajpheart.00043.2015","volume":"309","author":"MB Nelson","year":"2015","unstructured":"Nelson MB, Swensen AC, Winden DR, Bodine JS, Bikman BT, Reynolds PR (2015) Cardiomyocyte mitochondrial respiration is reduced by receptor for advanced glycation end-product signaling in a ceramide-dependent manner. Am J Physiol Heart Circ Physiol 309:H63\u2013H69","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3204_CR26","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pharmthera.2016.11.013","volume":"172","author":"A Faria","year":"2017","unstructured":"Faria A, Persaud SJ (2017) Cardiac oxidative stress in diabetes: mechanisms and therapeutic potential. Pharmacol Ther 172:50\u201362","journal-title":"Pharmacol Ther"},{"key":"3204_CR27","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1002\/2211-5463.12284","volume":"7","author":"Z Hegab","year":"2017","unstructured":"Hegab Z, Mohamed TMA, Stafford N, Mamas M, Cartwright EJ, Oceandy D (2017) Advanced glycation end products reduce the calcium transient in cardiomyocytes by increasing production of reactive oxygen species and nitric oxide. FEBS Open Bio 7:1672\u20131685","journal-title":"FEBS Open Bio"},{"key":"3204_CR28","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1172\/JCI118175","volume":"96","author":"AM Schmidt","year":"1995","unstructured":"Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, Zhang J, Cao R, Yan SD, Brett J, Stern D (1995) Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Investig 96:1395\u20131403","journal-title":"J Clin Investig"},{"key":"3204_CR29","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1161\/CIRCRESAHA.113.301651","volume":"113","author":"M Luo","year":"2013","unstructured":"Luo M, Anderson ME (2013) Mechanisms of altered Ca(2)(+) handling in heart failure. Circ Res 113:690\u2013708","journal-title":"Circ Res"},{"key":"3204_CR30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cmet.2015.01.005","volume":"21","author":"PA Gorski","year":"2015","unstructured":"Gorski PA, Ceholski DK, Hajjar RJ (2015) Altered myocardial calcium cycling and energetics in heart failure\u2014a rational approach for disease treatment. Cell Metab 21:183\u2013194","journal-title":"Cell Metab"},{"key":"3204_CR31","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1006\/jmcc.2002.2084","volume":"34","author":"R Petrova","year":"2002","unstructured":"Petrova R, Yamamoto Y, Muraki K, Yonekura H, Sakurai S, Watanabe T, Li H, Takeuchi M, Makita Z, Kato I, Takasawa S, Okamoto H, Imaizumi Y, Yamamoto H (2002) Advanced glycation endproduct-induced calcium handling impairment in mouse cardiac myocytes. J Mol Cell Cardiol 34:1425\u20131431","journal-title":"J Mol Cell Cardiol"},{"key":"3204_CR32","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0008-6363(00)00062-6","volume":"46","author":"G Kotsanas","year":"2000","unstructured":"Kotsanas G, Delbridge LM, Wendt IR (2000) Stimulus interval-dependent differences in Ca2+ transients and contractile responses of diabetic rat cardiomyocytes. Cardiovasc Res 46:450\u2013462","journal-title":"Cardiovasc Res"},{"key":"3204_CR33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000364779","volume":"129","author":"D Yan","year":"2014","unstructured":"Yan D, Luo X, Li Y, Liu W, Deng J, Zheng N, Gao K, Huang Q, Liu J (2014) Effects of advanced glycation end products on calcium handling in cardiomyocytes. Cardiology 129:75\u201383","journal-title":"Cardiology"},{"key":"3204_CR34","first-page":"e84969","volume":"1","author":"W Zhu","year":"2016","unstructured":"Zhu W, Tsang S, Browe DM, Woo AY, Huang Y, Xu C, Liu JF, Lv F, Zhang Y, Xiao RP (2016) Interaction of beta1-adrenoceptor with RAGE mediates cardiomyopathy via CaMKII signaling. JCI Insight 1:e84969","journal-title":"JCI Insight"},{"key":"3204_CR35","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ejphar.2015.07.045","volume":"764","author":"Q Yuan","year":"2015","unstructured":"Yuan Q, Zhan L, Zhou QY, Zhang LL, Chen XM, Hu XM, Yuan XC (2015) SIRT2 regulates microtubule stabilization in diabetic cardiomyopathy. Eur J Pharmacol 764:554\u2013561","journal-title":"Eur J Pharmacol"},{"key":"3204_CR36","doi-asserted-by":"crossref","first-page":"6634","DOI":"10.3892\/mmr.2017.7446","volume":"16","author":"D Yang","year":"2017","unstructured":"Yang D, Liu W, Ma L, Wang Y, Ma J, Jiang M, Deng X, Huang F, Yang T, Chen M (2017) Profilin1 contributes to cardiac injury induced by advanced glycation endproducts in rats. Mol Med Rep 16:6634\u20136641","journal-title":"Mol Med Rep"},{"key":"3204_CR37","first-page":"50","volume":"26","author":"S Yamagishi","year":"2008","unstructured":"Yamagishi S, Nakamura K, Matsui T, Ueda S, Noda Y, Imaizumi T (2008) Inhibitors of advanced glycation end products (AGEs): potential utility for the treatment of cardiovascular disease. Cardiovasc Ther 26:50\u201358","journal-title":"Cardiovasc Ther"},{"key":"3204_CR38","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1073\/pnas.95.3.1301","volume":"95","author":"B Corman","year":"1998","unstructured":"Corman B, Duriez M, Poitevin P, Heudes D, Bruneval P, Tedgui A, Levy BI (1998) Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy. Proc Natl Acad Sci USA 95:1301\u20131306","journal-title":"Proc Natl Acad Sci USA"},{"key":"3204_CR39","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1161\/hy1001.096211","volume":"38","author":"C Cantini","year":"2001","unstructured":"Cantini C, Kieffer P, Corman B, Liminana P, Atkinson J, Lartaud-Idjouadiene I (2001) Aminoguanidine and aortic wall mechanics, structure, and composition in aged rats. Hypertension 38:943\u2013948","journal-title":"Hypertension"},{"key":"3204_CR40","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0021-9150(97)00192-5","volume":"136","author":"S Panagiotopoulos","year":"1998","unstructured":"Panagiotopoulos S, O\u2019Brien RC, Bucala R, Cooper ME, Jerums G (1998) Aminoguanidine has an anti-atherogenic effect in the cholesterol-fed rabbit. Atherosclerosis 136:125\u2013131","journal-title":"Atherosclerosis"},{"key":"3204_CR41","doi-asserted-by":"crossref","first-page":"9441","DOI":"10.1073\/pnas.91.20.9441","volume":"91","author":"R Bucala","year":"1994","unstructured":"Bucala R, Makita Z, Vega G, Grundy S, Koschinsky T, Cerami A, Vlassara H (1994) Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. Proc Natl Acad Sci USA 91:9441\u20139445","journal-title":"Proc Natl Acad Sci USA"},{"key":"3204_CR42","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.abb.2003.08.013","volume":"419","author":"PJ Thornalley","year":"2003","unstructured":"Thornalley PJ (2003) Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Arch Biochem Biophys 419:31\u201340","journal-title":"Arch Biochem Biophys"},{"key":"3204_CR43","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1152\/japplphysiol.00988.2005","volume":"100","author":"AF Ceylan-Isik","year":"2006","unstructured":"Ceylan-Isik AF, Wu S, Li Q, Li SY, Ren J (2006) High-dose benfotiamine rescues cardiomyocyte contractile dysfunction in streptozotocin-induced diabetes mellitus. J Appl Physiol (1985) 100:150\u2013156","journal-title":"J Appl Physiol (1985)"},{"key":"3204_CR44","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/HJH.0b013e328013e7dd","volume":"25","author":"SJ Zieman","year":"2007","unstructured":"Zieman SJ, Melenovsky V, Clattenburg L, Corretti MC, Capriotti A, Gerstenblith G, Kass DA (2007) Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension. J Hypertens 25:577\u2013583","journal-title":"J Hypertens"},{"key":"3204_CR45","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1073\/pnas.95.8.4630","volume":"95","author":"BH Wolffenbuttel","year":"1998","unstructured":"Wolffenbuttel BH, Boulanger CM, Crijns FR, Huijberts MS, Poitevin P, Swennen GN, Vasan S, Egan JJ, Ulrich P, Cerami A, Levy BI (1998) Breakers of advanced glycation end products restore large artery properties in experimental diabetes. Proc Natl Acad Sci USA 95:4630\u20134634","journal-title":"Proc Natl Acad Sci USA"},{"key":"3204_CR46","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.RES.0000065620.39919.20","volume":"92","author":"R Candido","year":"2003","unstructured":"Candido R, Forbes JM, Thomas MC, Thallas V, Dean RG, Burns WC, Tikellis C, Ritchie RH, Twigg SM, Cooper ME, Burrell LM (2003) A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes. Circ Res 92:785\u2013792","journal-title":"Circ Res"},{"key":"3204_CR47","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1073\/pnas.98.3.1171","volume":"98","author":"PV Vaitkevicius","year":"2001","unstructured":"Vaitkevicius PV, Lane M, Spurgeon H, Ingram DK, Roth GS, Egan JJ, Vasan S, Wagle DR, Ulrich P, Brines M, Wuerth JP, Cerami A, Lakatta EG (2001) A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys. Proc Natl Acad Sci USA 98:1171\u20131175","journal-title":"Proc Natl Acad Sci USA"},{"key":"3204_CR48","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1161\/hc3801.097806","volume":"104","author":"DA Kass","year":"2001","unstructured":"Kass DA, Shapiro EP, Kawaguchi M, Capriotti AR, Scuteri A, deGroof RC, Lakatta EG (2001) Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation 104:1464\u20131470","journal-title":"Circulation"},{"key":"3204_CR49","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cardfail.2004.09.010","volume":"11","author":"WC Little","year":"2005","unstructured":"Little WC, Zile MR, Kitzman DW, Hundley WG, O\u2019Brien TX, Degroof RC (2005) The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure. J Card Fail 11:191\u2013195","journal-title":"J Card Fail"},{"key":"3204_CR50","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/eurjhf\/hfr067","volume":"13","author":"JW Hartog","year":"2011","unstructured":"Hartog JW, Willemsen S, van Veldhuisen DJ, Posma JL, van Wijk LM, Hummel YM, Hillege HL, Voors AA (2011) Effects of alagebrium, an advanced glycation endproduct breaker, on exercise tolerance and cardiac function in patients with chronic heart failure. Eur J Heart Fail 13:899\u2013908","journal-title":"Eur J Heart Fail"},{"key":"3204_CR51","doi-asserted-by":"crossref","first-page":"E323","DOI":"10.1152\/ajpendo.00024.2008","volume":"295","author":"C Tikellis","year":"2008","unstructured":"Tikellis C, Thomas MC, Harcourt BE, Coughlan MT, Pete J, Bialkowski K, Tan A, Bierhaus A, Cooper ME, Forbes JM (2008) Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs. Am J Physiol Endocrinol Metab 295:E323\u2013E330","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3204_CR52","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/eurjhf\/hfp070","volume":"11","author":"JM Nielsen","year":"2009","unstructured":"Nielsen JM, Kristiansen SB, Norregaard R, Andersen CL, Denner L, Nielsen TT, Flyvbjerg A, Botker HE (2009) Blockage of receptor for advanced glycation end products prevents development of cardiac dysfunction in db\/db type 2 diabetic mice. Eur J Heart Fail 11:638\u2013647","journal-title":"Eur J Heart Fail"},{"key":"3204_CR53","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00395-009-0071-x","volume":"105","author":"SH Ihm","year":"2010","unstructured":"Ihm SH, Chang K, Kim HY, Baek SH, Youn HJ, Seung KB, Kim JH (2010) Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor. Basic Res Cardiol 105:399\u2013407","journal-title":"Basic Res Cardiol"},{"key":"3204_CR54","doi-asserted-by":"crossref","first-page":"E155","DOI":"10.1073\/pnas.1522288113","volume":"113","author":"A Bangert","year":"2016","unstructured":"Bangert A, Andrassy M, Muller AM, Bockstahler M, Fischer A, Volz CH, Leib C, Goser S, Korkmaz-Icoz S, Zittrich S, Jungmann A, Lasitschka F, Pfitzer G, Muller OJ, Katus HA, Kaya Z (2016) Critical role of RAGE and HMGB1 in inflammatory heart disease. Proc Natl Acad Sci USA 113:E155\u2013E164","journal-title":"Proc Natl Acad Sci USA"},{"key":"3204_CR55","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1253\/circj.CJ-13-1235","volume":"78","author":"WI Yang","year":"2014","unstructured":"Yang WI, Lee D, Lee DL, Hong SY, Lee SH, Kang SM, Choi DH, Jang Y, Kim SH, Park S (2014) Blocking the receptor for advanced glycation end product activation attenuates autoimmune myocarditis. Circ J 78:1197\u20131205","journal-title":"Circ J"},{"key":"3204_CR56","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1161\/CIRCULATIONAHA.105.575993","volume":"113","author":"LG Bucciarelli","year":"2006","unstructured":"Bucciarelli LG, Kaneko M, Ananthakrishnan R, Harja E, Lee LK, Hwang YC, Lerner S, Bakr S, Li Q, Lu Y, Song F, Qu W, Gomez T, Zou YS, Yan SF, Schmidt AM, Ramasamy R (2006) Receptor for advanced-glycation end products: key modulator of myocardial ischemic injury. Circulation 113:1226\u20131234","journal-title":"Circulation"},{"key":"3204_CR57","doi-asserted-by":"crossref","first-page":"H1823","DOI":"10.1152\/ajpheart.01210.2007","volume":"294","author":"A Aleshin","year":"2008","unstructured":"Aleshin A, Ananthakrishnan R, Li Q, Rosario R, Lu Y, Qu W, Song F, Bakr S, Szabolcs M, D\u2019Agati V, Liu R, Homma S, Schmidt AM, Yan SF, Ramasamy R (2008) RAGE modulates myocardial injury consequent to LAD infarction via impact on JNK and STAT signaling in a murine model. Am J Physiol Heart Circ Physiol 294:H1823\u2013H1832","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3204_CR58","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jconrel.2015.09.006","volume":"217","author":"H Park","year":"2015","unstructured":"Park H, Ku SH, Park H, Hong J, Kim D, Choi BR, Pak HN, Lee MH, Mok H, Jeong JH, Choi D, Kim SH, Joung B (2015) RAGE siRNA-mediated gene silencing provides cardioprotection against ventricular arrhythmias in acute ischemia and reperfusion. J Control Release 217:315\u2013326","journal-title":"J Control Release"},{"key":"3204_CR59","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jcmg.2011.09.016","volume":"5","author":"Y Tekabe","year":"2012","unstructured":"Tekabe Y, Luma J, Li Q, Schmidt AM, Ramasamy R, Johnson LL (2012) Imaging of receptors for advanced glycation end products in experimental myocardial ischemia and reperfusion injury. JACC Cardiovasc Imaging 5:59\u201367","journal-title":"JACC Cardiovasc Imaging"},{"key":"3204_CR60","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/CS20080494","volume":"116","author":"AZ Kalea","year":"2009","unstructured":"Kalea AZ, Schmidt AM, Hudson BI (2009) RAGE: a novel biological and genetic marker for vascular disease. Clin Sci (Lond) 116:621\u2013637","journal-title":"Clin Sci (Lond)"},{"key":"3204_CR61","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11739-009-0300-1","volume":"4","author":"N Vazzana","year":"2009","unstructured":"Vazzana N, Santilli F, Cuccurullo C, Davi G (2009) Soluble forms of RAGE in internal medicine. Intern Emerg Med 4:389\u2013401","journal-title":"Intern Emerg Med"},{"key":"3204_CR62","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/2012","volume":"4","author":"L Park","year":"1998","unstructured":"Park L, Raman KG, Lee KJ, Lu Y, Ferran LJ Jr, Chow WS, Stern D, Schmidt AM (1998) Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med 4:1025\u20131031","journal-title":"Nat Med"},{"key":"3204_CR63","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1161\/01.CIR.0000039325.03698.36","volume":"106","author":"LG Bucciarelli","year":"2002","unstructured":"Bucciarelli LG, Wendt T, Qu W, Lu Y, Lalla E, Rong LL, Goova MT, Moser B, Kislinger T, Lee DC, Kashyap Y, Stern DM, Schmidt AM (2002) RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice. Circulation 106:2827\u20132835","journal-title":"Circulation"},{"key":"3204_CR64","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s12272-014-0527-x","volume":"38","author":"SH Ku","year":"2015","unstructured":"Ku SH, Hong J, Moon HH, Jeong JH, Mok H, Park S, Choi D, Kim SH (2015) Deoxycholic acid-modified polyethylenimine based nanocarriers for RAGE siRNA therapy in acute myocardial infarction. Arch Pharm Res 38:1317\u20131324","journal-title":"Arch Pharm Res"},{"key":"3204_CR65","doi-asserted-by":"crossref","first-page":"11923","DOI":"10.3390\/ijms130911923","volume":"13","author":"C Guo","year":"2012","unstructured":"Guo C, Zeng X, Song J, Zhang M, Wang H, Xu X, Du F, Chen B (2012) A soluble receptor for advanced glycation end-products inhibits hypoxia\/reoxygenation-induced apoptosis in rat cardiomyocytes via the mitochondrial pathway. Int J Mol Sci 13:11923\u201311940","journal-title":"Int J Mol Sci"},{"key":"3204_CR66","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1161\/01.ATV.0000190660.32863.cd","volume":"25","author":"H Koyama","year":"2005","unstructured":"Koyama H, Shoji T, Yokoyama H, Motoyama K, Mori K, Fukumoto S, Emoto M, Shoji T, Tamei H, Matsuki H, Sakurai S, Yamamoto Y, Yonekura H, Watanabe T, Yamamoto H, Nishizawa Y (2005) Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 25:2587\u20132593","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3204_CR67","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.numecd.2010.11.008","volume":"22","author":"D Leonardis","year":"2012","unstructured":"Leonardis D, Basta G, Mallamaci F, Cutrupi S, Pizzini P, Tripepi R, Tripepi G, De Caterina R, Zoccali C (2012) Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD). Nutr Metab Cardiovasc Dis 22:748\u2013755","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"3204_CR68","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.metabol.2006.05.007","volume":"55","author":"S Yamagishi","year":"2006","unstructured":"Yamagishi S, Adachi H, Nakamura K, Matsui T, Jinnouchi Y, Takenaka K, Takeuchi M, Enomoto M, Furuki K, Hino A, Shigeto Y, Imaizumi T (2006) Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects. Metabolism 55:1227\u20131231","journal-title":"Metabolism"},{"key":"3204_CR69","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.atherosclerosis.2011.05.023","volume":"217","author":"XY Cai","year":"2011","unstructured":"Cai XY, Lu L, Wang YN, Jin C, Zhang RY, Zhang Q, Chen QJ, Shen WF (2011) Association of increased S100B, S100A6 and S100P in serum levels with acute coronary syndrome and also with the severity of myocardial infarction in cardiac tissue of rat models with ischemia\u2013reperfusion injury. Atherosclerosis 217:536\u2013542","journal-title":"Atherosclerosis"},{"key":"3204_CR70","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.3390\/molecules14103869","volume":"14","author":"N Kubodera","year":"2009","unstructured":"Kubodera N (2009) A new look at the most successful prodrugs for active vitamin D (D hormone): alfacalcidol and doxercalciferol. Molecules 14:3869\u20133880","journal-title":"Molecules"},{"key":"3204_CR71","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0955-2863(02)00183-3","volume":"13","author":"RG Mehta","year":"2002","unstructured":"Mehta RG, Mehta RR (2002) Vitamin D and cancer. J Nutr Biochem 13:252\u2013264","journal-title":"J Nutr Biochem"},{"key":"3204_CR72","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1572-5995(05)80040-7","volume":"30","author":"Y Tachibana","year":"2005","unstructured":"Tachibana Y, Tsuji M (2005) Structure-activity relationships of naturally occurring active forms of vitamin D analogues. Stud Nat Prod Chem 30:483\u2013513","journal-title":"Stud Nat Prod Chem"},{"key":"3204_CR73","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1248\/bpb.22.371","volume":"22","author":"N Tsugawa","year":"1999","unstructured":"Tsugawa N, Nakagawa K, Kawamoto Y, Tachibana Y, Hayashi T, Ozono K, Okano T (1999) Biological activity profiles of 1alpha,25-dihydroxyvitamin D2, D3, D4, D7, and 24-epi-1alpha,25-dihydroxyvitamin D2. Biol Pharm Bull 22:371\u2013377","journal-title":"Biol Pharm Bull"},{"key":"3204_CR74","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1056\/NEJMcp1009570","volume":"364","author":"CJ Rosen","year":"2011","unstructured":"Rosen CJ (2011) Clinical practice. Vitamin D insufficiency. N Engl J Med 364:248\u2013254","journal-title":"N Engl J Med"},{"key":"3204_CR75","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3945\/ajcn.111.031070","volume":"95","author":"L Tripkovic","year":"2012","unstructured":"Tripkovic L, Lambert H, Hart K, Smith CP, Bucca G, Penson S, Chope G, Hypponen E, Berry J, Vieth R, Lanham-New S (2012) Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr 95:1357\u20131364","journal-title":"Am J Clin Nutr"},{"key":"3204_CR76","doi-asserted-by":"crossref","first-page":"752","DOI":"10.4065\/mcp.2010.0138","volume":"85","author":"KA Kennel","year":"2010","unstructured":"Kennel KA, Drake MT, Hurley DL (2010) Vitamin D deficiency in adults: when to test and how to treat. Mayo Clin Proc 85:752\u2013757 (quiz 757\u2013758)","journal-title":"Mayo Clin Proc"},{"key":"3204_CR77","first-page":"109275","volume":"2015","author":"I Mozos","year":"2015","unstructured":"Mozos I, Marginean O (2015) Links between vitamin D deficiency and cardiovascular diseases. Biomed Res Int 2015:109275","journal-title":"Biomed Res Int"},{"key":"3204_CR78","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1079\/BJN20051544","volume":"94","author":"A Zittermann","year":"2005","unstructured":"Zittermann A, Schleithoff SS, Koerfer R (2005) Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr 94:483\u2013492","journal-title":"Br J Nutr"},{"key":"3204_CR79","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0140-6736(89)91722-4","volume":"1","author":"J Elford","year":"1989","unstructured":"Elford J, Phillips AN, Thomson AG, Shaper AG (1989) Migration and geographic variations in ischaemic heart disease in Great Britain. Lancet 1:343\u2013346","journal-title":"Lancet"},{"issue":"4","key":"3204_CR80","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3390\/nu9040328","volume":"9","author":"G Jean","year":"2017","unstructured":"Jean G, Souberbielle JC, Chazot C (2017) Vitamin D in chronic kidney disease and dialysis Patients. Nutrients 9(4):328","journal-title":"Nutrients"},{"key":"3204_CR81","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1093\/ndt\/gfr763","volume":"27","author":"YJ Oh","year":"2012","unstructured":"Oh YJ, Kim M, Lee H, Lee JP, Kim H, Kim S, Oh KH, Joo KW, Lim CS, Kim S, Kim YS, Kim DK (2012) A threshold value of estimated glomerular filtration rate that predicts changes in serum 25-hydroxyvitamin D levels: 4th Korean National Health and Nutritional Examination Survey 2008. Nephrol Dial Transplant 27:2396\u20132403","journal-title":"Nephrol Dial Transplant"},{"key":"3204_CR82","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/j.ajkd.2011.03.020","volume":"58","author":"S Pilz","year":"2011","unstructured":"Pilz S, Iodice S, Zittermann A, Grant WB, Gandini S (2011) Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies. Am J Kidney Dis 58:374\u2013382","journal-title":"Am J Kidney Dis"},{"key":"3204_CR83","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1210\/jc.2014-4551","volume":"100","author":"D Durup","year":"2015","unstructured":"Durup D, Jorgensen HL, Christensen J, Tjonneland A, Olsen A, Halkjaer J, Lind B, Heegaard AM, Schwarz P (2015) A reverse J-shaped association between serum 25-hydroxyvitamin D and cardiovascular disease mortality: the CopD study. J Clin Endocrinol Metab 100:2339\u20132346","journal-title":"J Clin Endocrinol Metab"},{"key":"3204_CR84","doi-asserted-by":"crossref","first-page":"810","DOI":"10.3945\/ajcn.116.140392","volume":"105","author":"R Zhang","year":"2017","unstructured":"Zhang R, Li B, Gao X, Tian R, Pan Y, Jiang Y, Gu H, Wang Y, Wang Y, Liu G (2017) Serum 25-hydroxyvitamin D and the risk of cardiovascular disease: dose-response meta-analysis of prospective studies. Am J Clin Nutr 105:810\u2013819","journal-title":"Am J Clin Nutr"},{"key":"3204_CR85","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa1809944","volume":"380","author":"JE Manson","year":"2019","unstructured":"Manson JE, Cook NR, Lee IM, Christen W, Bassuk SS, Mora S, Gibson H, Gordon D, Copeland T, D\u2019Agostino D, Friedenberg G, Ridge C, Bubes V, Giovannucci EL, Willett WC, Buring JE (2019) Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med 380:33\u201344","journal-title":"N Engl J Med"},{"key":"3204_CR86","doi-asserted-by":"crossref","first-page":"e0174298","DOI":"10.1371\/journal.pone.0174298","volume":"12","author":"D Qi","year":"2017","unstructured":"Qi D, Nie XL, Wu S, Cai J (2017) Vitamin D and hypertension: prospective study and meta-analysis. PLoS One 12:e0174298","journal-title":"PLoS One"},{"key":"3204_CR87","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10654-013-9790-2","volume":"28","author":"SK Kunutsor","year":"2013","unstructured":"Kunutsor SK, Apekey TA, Steur M (2013) Vitamin D and risk of future hypertension: meta-analysis of 283,537 participants. Eur J Epidemiol 28:205\u2013221","journal-title":"Eur J Epidemiol"},{"key":"3204_CR88","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S2213-8587(14)70113-5","volume":"2","author":"KS Vimaleswaran","year":"2014","unstructured":"Vimaleswaran KS, Cavadino A, Berry DJ, Jorde R, Dieffenbach AK, Lu C, Alves AC, Heerspink HJ, Tikkanen E, Eriksson J, Wong A, Mangino M, Jablonski KA, Nolte IM, Houston DK, Ahluwalia TS, van der Most PJ, Pasko D, Zgaga L, Thiering E, Vitart V, Fraser RM, Huffman JE, de Boer RA, Schottker B, Saum KU, McCarthy MI, Dupuis J, Herzig KH, Sebert S, Pouta A, Laitinen J, Kleber ME, Navis G, Lorentzon M, Jameson K, Arden N, Cooper JA, Acharya J, Hardy R, Raitakari O, Ripatti S, Billings LK, Lahti J, Osmond C, Penninx BW, Rejnmark L, Lohman KK, Paternoster L, Stolk RP, Hernandez DG, Byberg L, Hagstrom E, Melhus H, Ingelsson E, Mellstrom D, Ljunggren O, Tzoulaki I, McLachlan S, Theodoratou E, Tiesler CM, Jula A, Navarro P, Wright AF, Polasek O, Wilson JF, Rudan I, Salomaa V, Heinrich J, Campbell H, Price JF, Karlsson M, Lind L, Michaelsson K, Bandinelli S, Frayling TM, Hartman CA, Sorensen TI, Kritchevsky SB, Langdahl BL, Eriksson JG, Florez JC, Spector TD, Lehtimaki T, Kuh D, Humphries SE, Cooper C, Ohlsson C, Marz W, de Borst MH, Kumari M, Kivimaki M, Wang TJ, Power C, Brenner H, Grimnes G, van der Harst P, Snieder H, Hingorani AD, Pilz S, Whittaker JC, Jarvelin MR, Hypponen E (2014) Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study. Lancet Diabetes Endocrinol 2:719\u2013729","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3204_CR89","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/ajh.2012.111","volume":"25","author":"T Larsen","year":"2012","unstructured":"Larsen T, Mose FH, Bech JN, Hansen AB, Pedersen EB (2012) Effect of cholecalciferol supplementation during winter months in patients with hypertension: a randomized, placebo-controlled trial. Am J Hypertens 25:1215\u20131222","journal-title":"Am J Hypertens"},{"key":"3204_CR90","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/jamainternmed.2015.0237","volume":"175","author":"LA Beveridge","year":"2015","unstructured":"Beveridge LA, Struthers AD, Khan F, Jorde R, Scragg R, Macdonald HM, Alvarez JA, Boxer RS, Dalbeni A, Gepner AD, Isbel NM, Larsen T, Nagpal J, Petchey WG, Stricker H, Strobel F, Tangpricha V, Toxqui L, Vaquero MP, Wamberg L, Zittermann A, Witham MD (2015) Effect of vitamin D supplementation on blood pressure: a systematic review and meta-analysis incorporating individual patient data. JAMA Intern Med 175:745\u2013754","journal-title":"JAMA Intern Med"},{"key":"3204_CR91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.maturitas.2018.05.010","volume":"115","author":"M Apostolakis","year":"2018","unstructured":"Apostolakis M, Armeni E, Bakas P, Lambrinoudaki I (2018) Vitamin D and cardiovascular disease. Maturitas 115:1\u201322","journal-title":"Maturitas"},{"key":"3204_CR92","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.2013.7228","volume":"310","author":"C Robinson-Cohen","year":"2013","unstructured":"Robinson-Cohen C, Hoofnagle AN, Ix JH, Sachs MC, Tracy RP, Siscovick DS, Kestenbaum BR, de Boer IH (2013) Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events. JAMA 310:179\u2013188","journal-title":"JAMA"},{"key":"3204_CR93","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.atherosclerosis.2015.11.020","volume":"244","author":"AA Nargesi","year":"2016","unstructured":"Nargesi AA, Heidari B, Esteghamati S, Hafezi-Nejad N, Sheikhbahaei S, Pajouhi A, Nakhjavani M, Esteghamati A (2016) Contribution of vitamin D deficiency to the risk of coronary heart disease in subjects with essential hypertension. Atherosclerosis 244:165\u2013171","journal-title":"Atherosclerosis"},{"key":"3204_CR94","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3945\/ajcn.113.082602","volume":"100","author":"JA Ford","year":"2014","unstructured":"Ford JA, MacLennan GS, Avenell A, Bolland M, Grey A, Witham M (2014) Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and meta-analysis. Am J Clin Nutr 100:746\u2013755","journal-title":"Am J Clin Nutr"},{"key":"3204_CR95","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1210\/jc.2013-4178","volume":"99","author":"A Bajaj","year":"2014","unstructured":"Bajaj A, Stone KL, Peters K, Parimi N, Barrett-Connor E, Bauer D, Cawthon PM, Ensrud KE, Hoffman AR, Orwoll E, Schernhammer ES (2014) Circulating vitamin D, supplement use, and cardiovascular disease risk: the MrOS sleep study. J Clin Endocrinol Metab 99:3256\u20133262","journal-title":"J Clin Endocrinol Metab"},{"key":"3204_CR96","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jneuroim.2017.10.002","volume":"313","author":"Z Nie","year":"2017","unstructured":"Nie Z, Ji XC, Wang J, Zhang HX (2017) Serum levels of 25-hydroxyvitamin D predicts infarct volume and mortality in ischemic stroke patients. J Neuroimmunol 313:41\u201345","journal-title":"J Neuroimmunol"},{"key":"3204_CR97","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s12603-016-0821-z","volume":"21","author":"H Qiu","year":"2017","unstructured":"Qiu H, Wang M, Mi D, Zhao J, Tu W, Liu Q (2017) Vitamin D status and the risk of recurrent stroke and mortality in ischemic stroke patients: data from a 24-month follow-up study in China. J Nutr Health Aging 21:766\u2013771","journal-title":"J Nutr Health Aging"},{"key":"3204_CR98","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.amjcard.2010.05.027","volume":"106","author":"JL Anderson","year":"2010","unstructured":"Anderson JL, May HT, Horne BD, Bair TL, Hall NL, Carlquist JF, Lappe DL, Muhlestein JB (2010) Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 106:963\u2013968","journal-title":"Am J Cardiol"},{"key":"3204_CR99","doi-asserted-by":"crossref","first-page":"e001278","DOI":"10.1161\/JAHA.114.001278","volume":"3","author":"N Bansal","year":"2014","unstructured":"Bansal N, Zelnick L, Robinson-Cohen C, Hoofnagle AN, Ix JH, Lima JA, Shoben AB, Peralta CA, Siscovick DS, Kestenbaum B, de Boer IH (2014) Serum parathyroid hormone and 25-hydroxyvitamin D concentrations and risk of incident heart failure: the multi-ethnic study of atherosclerosis. J Am Heart Assoc 3:e001278","journal-title":"J Am Heart Assoc"},{"key":"3204_CR100","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1016\/j.jacc.2016.03.508","volume":"67","author":"KK Witte","year":"2016","unstructured":"Witte KK, Byrom R, Gierula J, Paton MF, Jamil HA, Lowry JE, Gillott RG, Barnes SA, Chumun H, Kearney LC, Greenwood JP, Plein S, Law GR, Pavitt S, Barth JH, Cubbon RM, Kearney MT (2016) Effects of vitamin D on cardiac function in patients with chronic HF: the VINDICATE study. J Am Coll Cardiol 67:2593\u20132603","journal-title":"J Am Coll Cardiol"},{"key":"3204_CR101","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1093\/eurheartj\/ehx235","volume":"38","author":"A Zittermann","year":"2017","unstructured":"Zittermann A, Ernst JB, Prokop S, Fuchs U, Dreier J, Kuhn J, Knabbe C, Birschmann I, Schulz U, Berthold HK, Pilz S, Gouni-Berthold I, Gummert JF, Dittrich M, Borgermann J (2017) Effect of vitamin D on all-cause mortality in heart failure (EVITA): a 3-year randomized clinical trial with 4000\u00a0IU vitamin D daily. Eur Heart J 38:2279\u20132286","journal-title":"Eur Heart J"},{"key":"3204_CR102","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/clc.22473","volume":"39","author":"WL Jiang","year":"2016","unstructured":"Jiang WL, Gu HB, Zhang YF, Xia QQ, Qi J, Chen JC (2016) Vitamin D supplementation in the treatment of chronic heart failure: a meta-analysis of randomized controlled trials. Clin Cardiol 39:56\u201361","journal-title":"Clin Cardiol"},{"key":"3204_CR103","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/jre.12613","volume":"54","author":"M Elenkova","year":"2019","unstructured":"Elenkova M, Tipton DA (2019) Vitamin D attenuates human gingival fibroblast inflammatory cytokine production following advanced glycation end product interaction with receptors for AGE. J Periodontal Res 54:154\u2013163","journal-title":"J Periodontal Res"},{"key":"3204_CR104","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/molehr\/gay014","volume":"24","author":"Z Merhi","year":"2018","unstructured":"Merhi Z, Buyuk E, Cipolla MJ (2018) Advanced glycation end products alter steroidogenic gene expression by granulosa cells: an effect partially reversible by vitamin D. Mol Hum Reprod 24:318\u2013326","journal-title":"Mol Hum Reprod"},{"key":"3204_CR105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.mce.2018.09.004","volume":"479","author":"Z Merhi","year":"2019","unstructured":"Merhi Z (2019) Vitamin D attenuates the effect of advanced glycation end products on anti-Mullerian hormone signaling. Mol Cell Endocrinol 479:87\u201392","journal-title":"Mol Cell Endocrinol"},{"key":"3204_CR106","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1002\/1873-3468.12278","volume":"590","author":"S Iqbal","year":"2016","unstructured":"Iqbal S, Alam MM, Naseem I (2016) Vitamin D prevents glycation of proteins: an in vitro study. FEBS Lett 590:2725\u20132736","journal-title":"FEBS Lett"},{"key":"3204_CR107","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.diabres.2013.03.008","volume":"100","author":"E Salum","year":"2013","unstructured":"Salum E, Kals J, Kampus P, Salum T, Zilmer K, Aunapuu M, Arend A, Eha J, Zilmer M (2013) Vitamin D reduces deposition of advanced glycation end-products in the aortic wall and systemic oxidative stress in diabetic rats. Diabetes Res Clin Pract 100:243\u2013249","journal-title":"Diabetes Res Clin Pract"},{"key":"3204_CR108","doi-asserted-by":"crossref","first-page":"F1059","DOI":"10.1152\/ajprenal.00051.2008","volume":"294","author":"Y Talmor","year":"2008","unstructured":"Talmor Y, Golan E, Benchetrit S, Bernheim J, Klein O, Green J, Rashid G (2008) Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells. Am J Physiol Renal Physiol 294:F1059\u2013F1064","journal-title":"Am J Physiol Renal Physiol"},{"key":"3204_CR109","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1475-2840-13-8","volume":"13","author":"T Zitman-Gal","year":"2014","unstructured":"Zitman-Gal T, Green J, Pasmanik-Chor M, Golan E, Bernheim J, Benchetrit S (2014) Vitamin D manipulates miR-181c, miR-20b and miR-15a in human umbilical vein endothelial cells exposed to a diabetic-like environment. Cardiovasc Diabetol 13:8","journal-title":"Cardiovasc Diabetol"},{"key":"3204_CR110","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1053\/j.jrn.2014.10.027","volume":"25","author":"M Sturmer","year":"2015","unstructured":"Sturmer M, Sebekova K, Fazeli G, Bahner U, Stab F, Heidland A (2015) 25-hydroxyvitamin D and advanced glycation endproducts in healthy and hypertensive subjects: are there interactions? J Ren Nutr 25:209\u2013216","journal-title":"J Ren Nutr"},{"key":"3204_CR111","doi-asserted-by":"crossref","first-page":"958097","DOI":"10.1155\/2015\/958097","volume":"2015","author":"K Sebekova","year":"2015","unstructured":"Sebekova K, Sturmer M, Fazeli G, Bahner U, Stab F, Heidland A (2015) Is vitamin D deficiency related to accumulation of advanced glycation end products, markers of inflammation, and oxidative stress in diabetic subjects? Biomed Res Int 2015:958097","journal-title":"Biomed Res Int"},{"key":"3204_CR112","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10654-018-0444-2","volume":"34","author":"J Chen","year":"2019","unstructured":"Chen J, van der Duin D, Campos-Obando N, Ikram MA, Nijsten TEC, Uitterlinden AG, Zillikens MC (2019) Serum 25-hydroxyvitamin D3 is associated with advanced glycation end products (AGEs) measured as skin autofluorescence: the Rotterdam study. Eur J Epidemiol 34:67\u201377","journal-title":"Eur J Epidemiol"},{"key":"3204_CR113","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12933-015-0250-z","volume":"14","author":"YH Krul-Poel","year":"2015","unstructured":"Krul-Poel YH, Agca R, Lips P, van Wijland H, Stam F, Simsek S (2015) Vitamin D status is associated with skin autofluorescence in patients with type 2 diabetes mellitus: a preliminary report. Cardiovasc Diabetol 14:89","journal-title":"Cardiovasc Diabetol"},{"key":"3204_CR114","doi-asserted-by":"crossref","first-page":"e99461","DOI":"10.1371\/journal.pone.0099461","volume":"9","author":"G Dreyer","year":"2014","unstructured":"Dreyer G, Tucker AT, Harwood SM, Pearse RM, Raftery MJ, Yaqoob MM (2014) Ergocalciferol and microcirculatory function in chronic kidney disease and concomitant vitamin d deficiency: an exploratory, double blind, randomised controlled trial. PLoS One 9:e99461","journal-title":"PLoS One"},{"key":"3204_CR115","doi-asserted-by":"crossref","first-page":"E886","DOI":"10.1210\/jc.2013-4374","volume":"99","author":"M Irani","year":"2014","unstructured":"Irani M, Minkoff H, Seifer DB, Merhi Z (2014) Vitamin D increases serum levels of the soluble receptor for advanced glycation end products in women with PCOS. J Clin Endocrinol Metab 99:E886\u2013E890","journal-title":"J Clin Endocrinol Metab"},{"key":"3204_CR116","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1620\/tjem.230.59","volume":"230","author":"JY Sung","year":"2013","unstructured":"Sung JY, Chung W, Kim AJ, Kim HS, Ro H, Chang JH, Lee HH, Jung JY (2013) Calcitriol treatment increases serum levels of the soluble receptor of advanced glycation end products in hemodialysis patients with secondary hyperparathyroidism. Tohoku J Exp Med 230:59\u201366","journal-title":"Tohoku J Exp Med"},{"key":"3204_CR117","doi-asserted-by":"crossref","first-page":"2801324","DOI":"10.1155\/2017\/2801324","volume":"2017","author":"C Torino","year":"2017","unstructured":"Torino C, Pizzini P, Cutrupi S, Tripepi R, Vilasi A, Tripepi G, Mallamaci F, Zoccali C (2017) Effect of vitamin D receptor activation on the AGE\/RAGE system and myeloperoxidase in chronic kidney disease patients. Oxid Med Cell Longev 2017:2801324","journal-title":"Oxid Med Cell Longev"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-019-03204-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-019-03204-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-019-03204-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T02:39:42Z","timestamp":1663814382000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-019-03204-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,27]]},"references-count":117,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["3204"],"URL":"https:\/\/doi.org\/10.1007\/s00018-019-03204-3","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,27]]},"assertion":[{"value":"31 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}